Research/art/teacher profile of a person
Name and surname:
RNDr. Petra Priščáková, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Priščáková
I.2 - Name
Petra
I.3 - Degrees
RNDr. PhD.
I.4 - Year of birth
1989
I.5 - Name of the workplace
Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava
I.6 - Address of the workplace
Dean’s Office FofM CU, Špitálska ulica 24, 813 72 Bratislava
I.8 - E-mail address
petra.priscakova@fmed.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/29928
I.10 - Name of the study field in which a person works at the university
General Medicine, Dental Medicine
I.11 - ORCID iD
0000-0001-7287-3837

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Natural Sciences
II.b - Year
2012
II.c - Study field and programme
Biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Natural Sciences
II.b - Year
2014
II.c - Study field and programme
Biology - programme Genetics
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Medicine
II.b - Year
2018
II.c - Study field and programme
7. 1. 21 pathological anatomy and forensic medicine
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Faculty of Medicine, Comenius University Bratislava 2018 -

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Course: Quality control of qPCR in molecular diagnostics TATAAbiocenter, Gothenburg Švédsko 2015
Course: Multiplex PCR TATAAbiocenter, Gothenburg Švédsko 2015

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Biology and human genetics General Medicine II. General Medicine
Biology and human genetics Dental Medicine II. Dental Medicine
Biology and human genetics Biomedical physics I. Biomedical physics
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
0
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
10
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
77
VI.1.b - Over the last six years
38
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
25 (SCOPUS) / 20 (WOS)
VI.1.b - Over the last six years
22 (SCOPUS) / 17 (WOS)
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
184
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
186 (WOS) / 203 (SCOPUS)
VI.1.b - Over the last six years
171 (WOS) / 185 (SCOPUS)
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Altanerova U, Jakubechova J, Benejova K, Priscakova P, Pesta M, Pitule P, Topolcan O, Kausitz J, Zduriencikova M, Repiska V, Altaner C. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes. Int J Cancer. 2019 Feb 15;144(4):897-908. doi: 10.1002/ijc.31792. Epub 2018 Sep 27. PMID: 30098225. (IF = 5,145, Q1)

2

Priščáková P, Minárik G, Repiská V. Candidate gene studies of diabetic retinopathy in human. Mol Biol Rep. 2016 Dec;43(12):1327-1345. doi: 10.1007/s11033-016-4075-y. Epub 2016 Oct 11. PMID: 27730450; PMCID: PMC5102952. (IF = 1,828, Q4)

3

Altanerova U, Jakubechova J, Benejova K, Priscakova P, Repiska V, Babelova A, Smolkova B, Altaner C. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes. Int J Cancer. 2021 Jan 1;148(1):128-139. doi: 10.1002/ijc.33188. Epub 2020 Aug 4. PMID: 32621791. (IF = 5,145, Q1)

4

Gbelcová H, Bakeš P, Priščáková P, Šišovský V, Hojsíková I, Straka Ľ, Konečný M, Markus J, D'Acunto CW, Ruml T, Böhmer D, Danihel Ľ, Repiská V. PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women. Anal Cell Pathol (Amst). 2015;2015:746856. doi: 10.1155/2015/746856. Epub 2015 May 31. PMID: 26114084; PMCID: PMC4465682. (IF = 0,459, Q4)

5

Fabišíková K, Hamidová O, Behulová RL, Závodná K, Priščáková P, Repiská V. Case Report: The Role of Molecular Analysis of the MUTYH Gene in Asymptomatic Individuals. Front Genet. 2020 Dec 15;11:590486. doi: 10.3389/fgene.2020.590486. PMID: 33384714; PMCID: PMC7770176. (IF = 4,599, Q2)

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Priščáková P, Svoboda M, Feketová Z, Hutník J, Repiská V, Gbelcová H, Gergely L. Syncytin-1, syncytin-2 and suppressyn in human health and disease. J Mol Med (Berl). 2023 Dec;101(12):1527-1542. doi: 10.1007/s00109-023-02385-6. Epub 2023 Oct 19. PMID: 37855856; PMCID: PMC10697888. (IF = 4,7, Q1)

2

Kováč J, Priščáková P, Gbelcová H, Heydari A, Žiaran S. Bioadhesive and Injectable Hydrogels and Their Correlation with Mesenchymal Stem Cells Differentiation for Cartilage Repair: A Mini-Review. Polymers (Basel). 2023 Oct 26;15(21):4228. doi: 10.3390/polym15214228. PMID: 37959908; PMCID: PMC10648146. (IF = 5,0, Q1)

3

Gbelcová H, Gergely L, Šišovský V, Straka Ľ, Böhmer D, Pastoráková A, Sušienková K, Repiská V, Korbeľ M, Danihel Ľ, Priščáková P. PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women. Physiol Res. 2022 Dec 27;71(Suppl 1):S125-S135. doi: 10.33549/physiolres.935030. PMID: 36592448; PMCID: PMC9854001. (IF = 1,94, Q3)

4

Altanerova U, Jakubechova J, Benejova K, Priscakova P, Repiska V, Babelova A, Smolkova B, Altaner C. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes. Int J Cancer. 2021 Jan 1;148(1):128-139. doi: 10.1002/ijc.33188. Epub 2020 Aug 4. PMID: 32621791. (IF = 5,145, Q1)

5

Priščáková P, Korbeľ M, Nižňanská Z, Letkovská K, Sušienková K, Repiská V, Böhmer D, Gbelcová H. A proper placental sampling for syncytin-1 analysis. Biotechniques. 2020 Dec;69(6):427-435. doi: 10.2144/btn-2020-0121. Epub 2020 Sep 24. PMID: 32967447. (IF = 1,993, Q4)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Álvarez-Garcia V, Tawil Y, Wise HM, Leslie NR. Mechanisms of PTEN loss in cancer: It's all about diversity. Semin Cancer Biol. 2019 Dec;59:66-79. doi: 10.1016/j.semcancer.2019.02.001. Epub 2019 Feb 7. PMID: 30738865.

2

Zhu Q, Ling X, Yang Y, Zhang J, Li Q, Niu X, Hu G, Chen B, Li H, Wang Y, Deng Z. Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy. Adv Sci (Weinh). 2019 Feb 1;6(6):1801899. doi: 10.1002/advs.201801899. PMID: 30937268; PMCID: PMC6425428.

3

Cecilia OM, José Alberto CG, José NP, Ernesto Germán CM, Ana Karen LC, Luis Miguel RP, Ricardo Raúl RR, Adolfo Daniel RC. Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology. J Diabetes Res. 2019 Aug 14;2019:8562408. doi: 10.1155/2019/8562408. PMID: 31511825; PMCID: PMC6710812.

4

Ferreira Soares DC, Domingues SC, Viana DB, Tebaldi ML. Polymer-hybrid nanoparticles: Current advances in biomedical applications. Biomed Pharmacother. 2020 Nov;131:110695. doi: 10.1016/j.biopha.2020.110695. Epub 2020 Sep 10. PMID: 32920512.

5

Melzer C, Rehn V, Yang Y, Bähre H, von der Ohe J, Hass R. Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells. Cancers (Basel). 2019 Jun 9;11(6):798. doi: 10.3390/cancers11060798. PMID: 31181850; PMCID: PMC6627807.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Prínos molekulárnych metód pre diferenciálnu diagnostiku gestačnej trofoblastovej choroby, VEGA 1/0559/22, VEGA, hlavný riešiteľ.

2

Senzibilizácia nádorových buniek prostaty účinkom statínov, VEGA 1/0405/22, VEGA, spoluriešiteľ.

3

SYNCYTÍN-1 ako nový marker preeklampsie, druhej najčastejšej príčiny úmrtia gravidných žien, MZSR 2018/40-LFUK-14. MZSR, spoluriešiteľ.

4

Genetické spektrum príčin vnútromaternicového úmrtia plodu na Slovensku, EÚ NextGenerationEU prostredníctvom Plánu obnovy a odolnosti SR v rámci projektu č. 09I0X-03-V04-00253

5

Molekulové mechanizmy vplyvu statínov na inhibíciu, proliferáciu a diferenciáciu vybraných kmeňových a nádorových buniek a ich aplikácia v regeneračnej medicíne. APVV-15-0217. APVV, spoluriešiteľ.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Vysoká škola chemicko-technologická Technická 5, 166 28 Praha 6, Česká republika 21.01.2015 -20.2.2015 pod vedením doc. Ing. Heleny Gbelcovej, Ph.D.
Vysoká škola chemicko-technologická Technická 5, 166 28 Praha 6, Česká republika 01.06.2015 -31.07.2015 pod vedením doc. Ing. Heleny Gbelcovej, Ph.D.

IX. - Other relevant facts

Date of last update
2025-02-10